PATHOGENESIS AND MODERN THERAPEUTIC STRATEGIES IN RHEUMATOID ARTHRITIS

dc.contributor.authorS. B. Parpieva
dc.contributor.authorE. A.Vasilevsky
dc.contributor.authorO.T.Dadabaev
dc.contributor.authorN. G. Kamalov
dc.date.accessioned2025-12-28T15:25:49Z
dc.date.issued2025-10-18
dc.description.abstractRheumatoid arthritis (RA) is a chronic, systemic autoimmune disease that primarily manifests as a persistent inflammatory synovitis, leading to progressive cartilage damage and bone erosion if left undertreated [6]. Affecting up to 1% of the global population, RA imposes a substantial burden on individuals and healthcare systems, often causing significant pain, functional disability, and a diminished quality of life [6]. The last two decades have witnessed a revolutionary shift in the management of RA.
dc.formatapplication/pdf
dc.identifier.urihttps://theconferencehub.com/index.php/tch/article/view/568
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/8906
dc.language.isoeng
dc.publisherThe Conference Hub
dc.relationhttps://theconferencehub.com/index.php/tch/article/view/568/581
dc.rightshttps://creativecommons.org/licenses/by/4.0
dc.sourceThe Conference Hub; 2025: ICHARSE-USA-OCTOBER; 46-49
dc.titlePATHOGENESIS AND MODERN THERAPEUTIC STRATEGIES IN RHEUMATOID ARTHRITIS
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
parpieva_2025_pathogenesis_and_modern_therapeutic_stra.pdf
item.page.filesection.size
300.7 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections